Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


09.10.2017

1 Am J Gastroenterol
1 Ann Intern Med
2 Arch Virol
1 Dig Dis Sci
2 Hepatology
1 J Hepatol
2 J Infect Dis
1 J Pediatr
5 J Viral Hepat
1 JAMA
2 Lancet Gastroenterol Hepatol
5 PLoS One
1 Transplantation
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. KECK C, Shetty A, Mischen B, Willner I, et al
    Hepatic Splenosis Masquerading as Hepatocellular Carcinoma in a Chronic Hepatitis C Patient.
    Am J Gastroenterol. 2017;112:1493.
    PubMed     Text format    


    Ann Intern Med

  2. BELPERIO PS, Chartier M, Ross DB, Alaigh P, et al
    Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.
    Ann Intern Med. 2017;167:499-504.
    PubMed     Text format     Abstract available


    Arch Virol

  3. ABD-ELSALAM S, Sharaf-Eldin M, Soliman S, Elfert A, et al
    Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice.
    Arch Virol. 2017 Oct 5. doi: 10.1007/s00705-017-3573.
    PubMed     Text format     Abstract available

  4. FERREIRA AC, Gomes-Gouvea MS, Lisboa-Neto G, Mendes-Correa MCJ, et al
    Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil.
    Arch Virol. 2017 Sep 30. doi: 10.1007/s00705-017-3562.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  5. XING J, Spradling PR, Moorman AC, Holmberg SD, et al
    A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Sep 30. doi: 10.1007/s10620-017-4762.
    PubMed     Text format     Abstract available


    Hepatology

  6. BIAN Y, Zhang Z, Sun Z, Zhao J, et al
    Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice.
    Hepatology. 2017;66:1067-1082.
    PubMed     Text format     Abstract available

  7. CAO Z, Liu Y, Ma L, Lu J, et al
    A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated-interferon alpha.
    Hepatology. 2017;66:1058-1066.
    PubMed     Text format     Abstract available


    J Hepatol

  8. LIEBER SR, Rice JP, Lucey MR, Bataller R, et al
    Controversies in Clinical Trials for Alcoholic Hepatitis.
    J Hepatol. 2017 Sep 28. pii: S0168-8278(17)32325.
    PubMed     Text format     Abstract available


    J Infect Dis

  9. BOEIJEN LL, Montanari NR, de Groen RA, van Oord GW, et al
    Mucosal-associated invariant T (MAIT) cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy.
    J Infect Dis. 2017 Aug 23. doi: 10.1093.
    PubMed     Text format     Abstract available

  10. HEIMER R, Binka M, Koester S, Grund JC, et al
    Recovery of Infectious Hepatitis C Virus from Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs.
    J Infect Dis. 2017 Aug 19. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Pediatr

  11. JITRARUCH S, Fitzpatrick E, Deheragoda M, Deganello A, et al
    Autoimmune Liver Disease in Children with Sickle Cell Disease.
    J Pediatr. 2017 Jul 20. pii: S0022-3476(17)30885.
    PubMed     Text format     Abstract available


    J Viral Hepat

  12. TANG L, Parker A, Flores Y, Dellario M, et al
    Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: highly effective in a predominantly black male patient population.
    J Viral Hepat. 2017 Oct 6. doi: 10.1111/jvh.12796.
    PubMed     Text format     Abstract available

  13. NORDMANN S, Vilotitch A, Roux P, Esterle L, et al
    Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH).
    J Viral Hepat. 2017 Oct 6. doi: 10.1111/jvh.12797.
    PubMed     Text format     Abstract available

  14. SRIDHAR S, Chan JFW, Yap DYH, Teng JLL, et al
    Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong.
    J Viral Hepat. 2017 Oct 6. doi: 10.1111/jvh.12799.
    PubMed     Text format     Abstract available

  15. CAMUS G, Han B, Asselah T, Hsieh D, et al
    Resistance Characterization of Ledipasvir and Velpatasvir in Hepatitis C Virus Genotype 4.
    J Viral Hepat. 2017 Oct 6. doi: 10.1111/jvh.12795.
    PubMed     Text format     Abstract available

  16. WEIL C, Mehta D, Koren G, Pinsky B, et al
    Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider.
    J Viral Hepat. 2017 Oct 6. doi: 10.1111/jvh.12800.
    PubMed     Text format     Abstract available


    JAMA

  17. VOELKER R
    The 8-Week Cure for Hepatitis C.
    JAMA. 2017;318:996.
    PubMed     Text format    


    Lancet Gastroenterol Hepatol

  18. ALFAIATE D, Negro F
    Nucleic acid polymers: much-needed hope for hepatitis D?
    Lancet Gastroenterol Hepatol. 2017 Sep 27. pii: S2468-1253(17)30292.
    PubMed     Text format    

  19. BAZINET M, Pantea V, Cebotarescu V, Cojuhari L, et al
    Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Lancet Gastroenterol Hepatol. 2017 Sep 27. pii: S2468-1253(17)30288.
    PubMed     Text format     Abstract available


    PLoS One

  20. GONZALES-GUSTAVSON E, Timoneda N, Fernandez-Cassi X, Caballero A, et al
    Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology.
    PLoS One. 2017;12:e0185911.
    PubMed     Text format     Abstract available

  21. NAGATY A, Abd El-Wahab EW
    Real-life results of sofosbuvir based therapy in chronic hepatitis C -naive and -experienced patients in Egypt.
    PLoS One. 2017;12:e0184654.
    PubMed     Text format     Abstract available

  22. NOSAKA T, Naito T, Hiramatsu K, Ohtani M, et al
    Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B.
    PLoS One. 2017;12:e0185442.
    PubMed     Text format     Abstract available

  23. YANG CK, Wang XK, Liao XW, Han CY, et al
    Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
    PLoS One. 2017;12:e0182208.
    PubMed     Text format     Abstract available

  24. BIADGO B, Shiferaw E, Woldu B, Alene KA, et al
    Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study.
    PLoS One. 2017;12:e0180416.
    PubMed     Text format     Abstract available


    Transplantation

  25. HEO NY, Mannalithara A, Kim D, Udompap P, et al
    Long-term Patient and Graft Survival of Kidney Transplant Recipients with Hepatitis C Virus Infection in the United States.
    Transplantation. 2017 Oct 3. doi: 10.1097/TP.0000000000001953.
    PubMed     Text format     Abstract available


    Virology

  26. AHN HS, Han SH, Kim YH, Park BJ, et al
    Adverse fetal outcomes in pregnant rabbits experimentally infected with rabbit hepatitis E virus.
    Virology. 2017;512:187-193.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: